• Molecular NamePhenformin
  • SynonymBeta-Pebg; Beta-Phenethybiguanide; Beta-Phenethylbiguanide; Fenformin; Fenformina [INN-Spanish]; N-Phenethylbiguanide Hydrochloride; PEDG; Phenethylbiguanide Hydrochloride; Phenethyldiguanide; Phenformin HCl; Phenformin Hydrochloride; Phenformine; Phenformine [INN-French]; Phenformine HCl; Phenforminum [INN-Latin]; Phenoformine Hydrochloride; Phenylethylbiguanide
  • Weight205.265
  • Drugbank_IDDB00914
  • ACS_NO114-86-3
  • Show 3D model
  • LogP (experiment)-0.83
  • LogP (predicted, AB/LogP v2.0)0.03
  • pka2.7, 11.8 (32°)
  • LogD (pH=7, predicted)-3.06
  • Solubility (experiment)210 mg/mLl
  • LogS (predicted, ACD/Labs)(ph=7)-0.15
  • LogSw (predicted, AB/LogsW2.0)0.23
  • Sw (mg/ml) (predicted, ACD/Labs)1.87
  • No.of HBond Donors6
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds4
  • TPSA102.78
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn anti-diabetic drug from the biguanide class.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability55.0
  • Protein binding16.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life10~15 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)LD50=900